복약 준수 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 약제별, 지역별 세분화 및 경쟁 구도(2020-2030년)
Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Medication, By Region and Competition, 2020-2030F
상품코드:1879261
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 복약 준수 시장은 2024년에 26억 6,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 5.30%로 성장하여 36억 3,000만 달러에 이를 것으로 예측됩니다.
복약 준수 솔루션은 환자가 처방된 약물의 복용량, 복용 시기, 복용 빈도를 일관되게 준수할 수 있도록 설계된 기술과 서비스를 포함합니다. 이 시장의 성장은 주로 당뇨병, 심혈관 질환과 같은 만성질환의 전 세계적인 유병률 증가, 장기 치료가 필요한 고령 인구 증가, 건강 관리를 위한 스마트폰의 보급 등 헬스케어 기술의 지속적인 발전에 의해 주도되고 있습니다. 또한, 환자 중심 케어 모델에 대한 관심이 높아지고 의료 생태계 전반의 협력이 강화되는 것도 성장의 원동력이 되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
26억 6,000만 달러
시장 규모 : 2030년
36억 3,000만 달러
CAGR : 2025-2030년
5.3%
성장 속도가 가장 빠른 부문
종양학
최대 시장
북미
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 복약 준수 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
유형별(하드웨어 중심, 소프트웨어 중심)
약제별(순환기계, 중추신경계, 당뇨병, 종양학, 소화기계, 근골격계, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 복약 준수 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 복약 준수 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 복약 준수 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 복약 준수 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카공화국
제10장 남미의 복약 준수 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)
제품 출시
최근 동향
제13장 세계의 복약 준수 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
AdhereTech Inc.
Cardinal Health Inc.
Everwell Technology Ltd
InhandPlus Inc.
Johnson & Johnson
Koninklijke Philips N.V.
McKesson Corporation
MedAdvisor International Pty Ltd
Medminder Systems, Inc.
Omnicell, Inc.
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
The Global Medication Adherence Market, valued at USD 2.66 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 3.63 Billion by 2030. Medication adherence solutions encompass technologies and services designed to ensure patients consistently follow prescribed medication regimens concerning dosage, timing, and frequency. This market's growth is primarily driven by the escalating global prevalence of chronic diseases, such as diabetes and cardiovascular conditions, the expanding geriatric population requiring long-term treatment, and continuous advancements in healthcare technology, including widespread smartphone adoption for health management. Further impetus comes from a growing emphasis on patient-centric care models and increasing collaborations across the healthcare ecosystem.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.66 Billion
Market Size 2030
USD 3.63 Billion
CAGR 2025-2030
5.3%
Fastest Growing Segment
Oncology
Largest Market
North America
Key Market Drivers
The escalating prevalence of chronic diseases represents a primary driver for the global medication adherence market. Conditions such as diabetes, cardiovascular disease, and respiratory ailments necessitate long-term medication regimens, often complex, for effective management and prevention of severe complications. The sheer scale of this challenge underscores the critical need for solutions that support consistent patient adherence. According to the International Diabetes Federation, in 2024, 589 million adults aged 20 to 79 years are living with diabetes, a condition demanding rigorous medication adherence to mitigate serious health consequences and healthcare burdens.
Key Market Challenges
The high cost of pharmaceuticals and patient cost-sharing presents a significant challenge to the growth of the Global Medication Adherence Market. When medication expenses become prohibitive, patients frequently resort to strategies such as reducing prescribed dosages, delaying refills, or entirely discontinuing essential treatments. This financial impediment directly undermines the utility and adoption of medication adherence solutions, as patients prioritize immediate cost reduction over long-term health management facilitated by adherence technologies.
Key Market Trends
The integration of Artificial Intelligence in adherence monitoring is fundamentally transforming how patients engage with their prescribed treatments. AI-powered platforms leverage advanced algorithms to analyze patient behavior, identify non-adherence patterns, and deliver highly personalized interventions, moving beyond generic reminders. These intelligent systems facilitate predictive analytics to pinpoint individuals at high risk of non-adherence, enabling proactive support. According to American Medical Association survey data, 66% of physicians reported using AI in their practices in 2024, a significant increase from 38% in 2023, demonstrating growing adoption of AI in clinical settings. This technological shift enhances the effectiveness of medication management by tailoring support to individual patient needs.
Key Market Players
AdhereTech Inc.
Cardinal Health Inc.
Everwell Technology Ltd
InhandPlus Inc.
Johnson & Johnson
Koninklijke Philips N.V.
McKesson Corporation
MedAdvisor International Pty Ltd
Medminder Systems, Inc.
Omnicell, Inc.
Report Scope:
In this report, the Global Medication Adherence Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Medication Adherence Market, By Type:
Hardware Centric
Software Centric
Medication Adherence Market, By Medication:
Cardiovascular
Central Nervous System
Diabetes
Oncology
Gastrointestinal
Musculoskeletal
Others
Medication Adherence Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Medication Adherence Market.
Available Customizations:
Global Medication Adherence Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Medication Adherence Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Hardware Centric, Software Centric)
5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Medication Adherence Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Medication
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Medication Adherence Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Medication
6.3.2. Canada Medication Adherence Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Medication
6.3.3. Mexico Medication Adherence Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Medication
7. Europe Medication Adherence Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Medication
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Medication Adherence Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Medication
7.3.2. France Medication Adherence Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Medication
7.3.3. United Kingdom Medication Adherence Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Medication
7.3.4. Italy Medication Adherence Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Medication
7.3.5. Spain Medication Adherence Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Medication
8. Asia Pacific Medication Adherence Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Medication
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Medication Adherence Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Medication
8.3.2. India Medication Adherence Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Medication
8.3.3. Japan Medication Adherence Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Medication
8.3.4. South Korea Medication Adherence Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Medication
8.3.5. Australia Medication Adherence Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Medication
9. Middle East & Africa Medication Adherence Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Medication
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Medication Adherence Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Medication
9.3.2. UAE Medication Adherence Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Medication
9.3.3. South Africa Medication Adherence Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Medication
10. South America Medication Adherence Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Medication
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Medication Adherence Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Medication
10.3.2. Colombia Medication Adherence Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Medication
10.3.3. Argentina Medication Adherence Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Medication
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Medication Adherence Market: SWOT Analysis
